NCT02565433

Prospective Assessment of Quality of Life in Patients Treated by Radiosurgery for Brain Metastases (PRAMECE-1302)

Prospective Assessment of Quality of Life in Patients Treated by Radiosurgery for Brain Metastases

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 52 (actual)
• Sponsor: Centre Oscar Lambret · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of the study is to assess prospectively the impact of radiosurgery on the quality of life in patients with brain metastases.

Detailed description

The patients who meet the selection criteria and who have accepted to participate at the study will answer different questionnaires of the study before radiosurgery and at 3, 6, 9 and 12 months after the treatment of brain metastases. Baseline examinations will be done before receiving the treatment during the hospitalisation for the Gamma Knife treatment, and then they will be repeated at the evaluation visits which are classically done every 3 months. MRI's will also be performed every 3 months. In this way, no additional travel or MRI will be carried out as part of the study.

Conditions

• Neoplasm Metastases

Interventions

Type	Name	Description
OTHER	questionnaire administration	Within 15 days before radiosurgery and then at 3, 6, 9, 12 months after radiosurgery, the patients who have accepted to participate will have to complete these questionnaires : QLQC30, BN20, IADL, HADS, MoCa, Edmonton Symptom Assessment Scale

Timeline

• Start date: 2014-02-05
• Primary completion: 2018-01-01
• Completion: 2018-06-01
• First posted: 2015-10-01
• Last updated: 2026-03-16

Locations

1 site across 1 country: France